ArticleFrontiers in pharmacology2026

Vonoprazan as an adjuvant to cisplatin: enhancing antitumor efficacy while mitigating nephrotoxicity and gastrointestinal adverse effects.

Faiz N Alenezi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.